Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance?
Alimentary Pharmacology & Therapeutics · 2026-05 · 63 (10) · 1427-1428
DOI: 10.1111/apt.70606 ↗Kurz gefasst
Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 17.03.2026. Verfasst von Heechul Nam und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Se…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
ORCID-Profile: Sung Won Lee
Zitieren
APA
Nam, H., & Lee, S. W. (2026). Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance?. Alimentary Pharmacology & Therapeutics, 63(10), 1427-1428. https://doi.org/10.1111/apt.70606
Vancouver
Nam H, Lee SW. Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance?. Alimentary Pharmacology & Therapeutics. 2026;63(10):1427-1428. doi:10.1111/apt.70606
BibTeX
@article{Nam2026,
author = {Nam, Heechul and Lee, Sung Won},
title = {Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance?},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {10},
pages = {1427--1428},
doi = {10.1111/apt.70606}
}
EUVIMED